GlobeNewsWire
10 Jul 2026, 12:50 UTC · 2h ago
NewsImpactScreener rates every claim in this story for market impact and maps it to the tickers most exposed.
What the story claims
4 claims · each scored for market impact
ADMA Biologics is accused of using 'channel stuffing' to artificially inflate its reported revenue. — Revenue manipulation through channel stuffing is a severe accounting red flag that typically leads to significant valuation corrections.
-0.80A securities fraud lawsuit alleges ADMA Biologics failed to disclose a related party transaction. — Undisclosed related party transactions suggest governance failures and potential conflicts of interest.
-0.60The complaint claims ADMA Biologics failed to maintain appropriate internal controls over financial reporting. — Weak internal controls increase the risk of further accounting errors or fraud, undermining investor confidence in financial statements.
-0.50Continue reading
6 related stories
Top 3 movers · tap to explore
The Schall Law Firm is seeking lead plaintiffs for a class action lawsuit against ADMA Biologics covering the period from August 9, 2024, to March 25, 2026. — While the lawsuit is a catalyst, the legal process is slow; the impact is lower than the underlying fraud allegations themselves.
-0.30Which stocks this story touches
The company is mentioned as the subject of a securities fraud lawsuit.
The company is facing a securities fraud class action lawsuit alleging false statements and channel stuffing.
The company is mentioned as the subject of a securities fraud lawsuit.
Free · No account
Get a free daily PDF briefing — the last 24 hours of news, with summaries and the market-impact score for each story, delivered an hour before the open.
We’ll watch
Pre-filled from this story — remove any you don’t want. Add more tickers & tags or fine-tune your watchlist anytime — every email has an edit link, no account needed.
Free forever · one email a day, max · unsubscribe in one click.How it works
How the impact breaks down
Where the story's weight lands
Stocks most exposed
Modeled from each name's sensitivity to this story
No stock impact ranking available yet.
GlobeNewsWire
2h ago
